newsfilter
← Latest News
Business Wire·

TherapeuticsMD Announces Full Year 2023 Financial Results

• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ:TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the